Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 10/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL6257862 | 1.00 | LSS (0.50) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL2544112 | 1.00 | LSS (0.50) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL6054967 | 1.00 | LSS (0.50) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL6261097 | 1.00 | LSS (0.50) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL6405436 | 1.00 | LSS (0.50) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL31472472 | 0.98 | LSS (0.52) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL29702366 | 0.98 | LSS (0.52) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL4151447 | 0.98 | LSS (0.52) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL2995826 | 0.98 | LSS (0.52) | LSSDNM1HTTSLC22A1KMT2A | |
| Sulfuric Acid SCHEMBL29702465 | 0.98 | LSS (0.52) | LSSDNM1HTTSLC22A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229195-A1 | RADIOLABELLED COMPOUNDS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-11-06 | — | — | WO | claimed |
| US-20250043039-A1 | HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER | ARLANXEO SINGAPORE PTE. LTD. (SG) | 2025-02-06 | — | — | US | claimed |
| EP-4448595-A1 | HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER | Arlanxeo Singapore Pte. Ltd. (SG) | 2024-10-23 | — | — | EP | claimed |
| WO-2024081696-A2 | COMPOSITIONS CONTAINING PHASE CHANGE MATERIALS, METHODS FOR FORMING OBJECTS USING THE SAME, AND METHOD FOR USING THE SAME | PHASE CHANGE ENERGY SOLUTIONS, INC. (US) | 2024-04-18 | — | — | WO | claimed |
| WO-2023108259-A1 | HALOGEN RECOVERY WITH OXIDANT AND PHASE TRANSFER CATALYST IN A PROCESS FOR HALOGENATING UNSATURATED ISOOLEFIN COPOLYMER | ARLANXEO SINGAPORE PTE. LTD. (SG) | 2023-06-22 | — | — | WO | claimed |
| CN-115232058-A | Synthesis method of gliclazide intermediate 1,2-cyclopentanedicarboxamide | 上海巽田科技股份有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-105980391-B | Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds | 昂皮瑞科公司 | 2021-09-03 | — | — | CN | claimed |
| CN-112608227-A | Method for preparing isononanoic acid from isononanol through green oxidation | 广东石油化工学院 | 2021-04-06 | — | — | CN | claimed |
| US-10265692-B2 | Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds | EMPIRIKO CORPORATION (US) | 2019-04-23 | — | — | US | claimed |
| US-20160365228-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION | 2016-12-15 | — | — | US | claimed |
| WO-2015089089-A1 | EX VIVO METHODS FOR PREDICTING AND CONFIRMING IN VIVO METABOLISM OF PHARMACEUTICALLY ACTIVE COMPOUNDS | EMPIRIKO CORPORATION (US) | 2015-06-18 | — | — | WO | claimed |
| US-20140335698-A1 | COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE | LAM RESEARCH CORPORATION (US) | 2014-11-13 | — | — | US | claimed |
| US-7696366-B2 | Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound | SHOWA DENKO K.K. (JP) | 2010-04-13 | — | — | US | claimed |
| US-7541312-B2 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2009-06-02 | — | — | US | claimed |
| EP-1725497-A4 | POROUS CARBONS FROM CARBOHYDRATES | TDA RESEARCH INC (US) | 2008-11-05 | — | — | EP | claimed |
| EP-1725497-A2 | POROUS CARBONS FROM CARBOHYDRATES | TDA RESEARCH, INC. (US) | 2006-11-29 | — | — | EP | claimed |
| US-20060216828-A1 | Rapid-response reversible dry surface CO2 detector | MERCURY ENTERPRISE, INC. | 2006-09-28 | — | — | US | claimed |
| WO-2005089145-A2 | POROUS CARBONS FROM CARBOHYDRATES | TDA RESEARCH, INC. (US) | 2005-09-29 | — | — | WO | claimed |
| US-20050207962-A1 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2005-09-22 | — | — | US | claimed |
| US-20050208248-A1 | Automotive fuel hose and method for producing the same | TOKAI RUBBER INDUSTRIES, LTD. (JP) | 2005-09-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10265692-B2 | Ex vivo methods for predicting and confirming in vivo metabolism of pharmaceutically active compounds | CYP3A43, CYP3A4, CYP2D6 | LSS 476/4885DNM1 1942/4885HTT 2603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.